Immunoglobulin g lymphocytotoxic antibodies in clinical liver transplantation: Studies toward further defining their significance

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Hepatology

• Publication date

  1995-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/HEP.1840210519PMID 7737641PMCID PMC2977952
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Biological Basis of and Strategies for Clinical Xenotransplantation

  1994cited by this paper
• Liver allograft rejection in sensitized recipients. Observations in a clinically relevant small animal model.

  1993cited by this paper
• THE LACK OF LONG‐TERM DETRIMENTAL EFFECTS ON LIVER ALLOGRAFTS CAUSED BY DONOR‐SPECIFIC ANTI‐HLA ANTIBODIES

  1993cited by this paper
• Ischemic‐type biliary complications after orthotopic liver transplantation

  1992cited by this paper
• THE ADVERSE IMPACT ON LIVER TRANSPLANTATION OF USING POSITIVE CYTOTOXIC CROSSMATCH DONORS 1, 2

  1992cited by this paper
• THE USE OF mARGINAL DONORS FOR LIVER TRANSPLANTATION A RETROSPECTIVE STUDY OF 365 LIVER DONORS 1,2

  1992cited by this paper
• Liver transplantation in positive cytotoxic crossmatch cases using FK506, high-dose steroids, and prostaglandin E1.

  1992cited by this paper
• A clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodies

  1992cited by this paper
• Immunopathology of Antibodies as Effectors of Orthotopic Liver Allograft Rejection

  1992cited by this paper
• Significance of a positive crossmatch on outcome in human liver transplantation.

  1992cited by this paper
• Preformed lymphocytotoxic antibodies: The effects of class, titer and specificity on liver vs. heart allografts

  1992cited by this paper
• Relevance of a positive crossmatch in liver transplantation

  1991cited by this paper
• The effect of soluble complement receptor type 1 on hyperacute allograft rejection.

  1991cited by this paper
• Positive crossmatch in primary human liver allografts under cyclosporine or FK 506 therapy.

  1991cited by this paper
• Protective effects of liver transplantation on a simultaneously transplanted kidney in a highly sensitized patient.

  1990cited by this paper
• Hyperacute rejection in liver transplantation: a case report.

  1989cited by this paper
• Evidence for hyperacute rejection of human liver grafts: The case of the canary kidneys

  1989cited by this paper
• Platelet crossmatching for kidney transplants by flow cytometry.

  1989cited by this paper
• HLA alloimmunization and blood requirements in orthotopic liver transplantation.

  1989cited by this paper
• Treatment of primary liver graft nonfunction with prostaglandin E1.

  1989cited by this paper
• INFLUENCE OF POSITIVE LYMPHOCYTE CROSSMATCH AND HLA MISMATCHING ON VANISHING BILE DUCT SYNDROME IN HUMAN LIVER ALLOGRAFTS

  1988cited by this paper
• Successful transplants across T warm‐positive crossmatches due to IgM antibodies

  1988cited by this paper
• RELATIONSHIP BETWEEN THE LIVER AND LYMPHOCYTOTOXIC ALLOANTIBODIES IN INBRED RATS: Specific Absorption by Nonparenchymal Liver Cells

  1988cited by this paper
• Signs of hyperacute rejection of liver grafts in rhesus monkeys after donor-specific presensitization.

  1987cited by this paper
• Successful sequential liver-kidney transplantation in a patient with performed lymphocytotoxic antibodies.

  1987cited by this paper
• A positive lymphocyte cross-match and major histocompatibility complex mismatching do not predict early rejection of liver transplants in patients treated with cyclosporine.

  1987cited by this paper
• HEPATIC TRANSPLANTATION INTO SENSITIZED RECIPIENTS: DEMONSTRATION OF HYPERACUTE REJECTION

  1987cited by this paper
• Hyperacute rejection of a human orthotopic liver allograft in a presensitized recipient

  1987cited by this paper
• Prolongation of Pig‐to‐Dog Renal Xenograft Survival by Modification of the Inflammatory Mediator Response

  1987cited by this paper
• DELAYED REJECTION OF HEART ALLOGRAFTS IN HYPERSENSITIZED RATS BY EXTRACORPOREAL DONOR‐SPECIFIC LIVER HEMOPERFUSION

  1986cited by this paper
• Interactions between liver allografts and lymphocytotoxic alloantibodies in inbred rats

  1986cited by this paper
• Biological protection with prostaglandins

  1985cited by this paper
• The effect of cyclosporine, total lymphoid irradiation, and cobra venom factor on hyperacute rejection.

  1985cited by this paper
• Liver transplantation against T cell-positive warm crossmatches.

  1984cited by this paper
• PROSTAGLANDIN AS AN EFFECTIVE ANTIREJECTION THERAPY IN RAT RENAL ALLOGRAFT RECIPIENTS

  1983cited by this paper
• HYPERACUTE RENAL ALLOGRAFT REJECTION IN THE RABBIT: VASOCONSTRICTION DEMONSTRATED BY MICROANGIOGRAPHY

  1983cited by this paper
• Complement biosynthesis by the human hepatoma-derived cell line HepG2.

  1982cited by this paper
• Alloimmunization following platelet transfusion: the absence of a dose- response relationship

  1981cited by this paper
• Alloimmunization following platelet transfusion: the absence of a dose-response relationship.

  1981cited by this paper
• Reversal of transplantation immunity by liver grafting

  1981cited by this paper
• Studies of hepatic synthesis in vivo of plasma proteins, including orosomucoid, transferrin, α-antitrypsin, C8, and factor B

  1980cited by this paper
• Fully allogeneic liver grafting in rats induces a state of systemic nonreactivity to donor transplantation antigens.

  1980cited by this paper
• Studies of hepatic synthesis in vivo of plasma proteins, including orosomucoid, transferrin, alpha 1-antitrypsin, C8, and factor B.

  1980cited by this paper
• Qualitative testing for circulating immune complexes by use of zone electrophoresis on agarose.

  1980cited by this paper
• Fifteen years of clinical liver transplantation.

  1979cited by this paper
• Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction.

  1974cited by this paper
• Immunopathological studies of orthotopic human liver allografts.

  1972cited by this paper
• Proposed New Method for Separating Isotopes

  1971cited by this paper
• Induction of Immunological Tolerance by Porcine Liver Allografts

  1969cited by this paper

• Comparison of Cardiac Allograft Vasculopathy Incidence Between Simultaneous Multi-Organ and Isolated Heart Transplant Recipients in the United States.

  2024cites this paper
• Detailed Analysis of Simultaneous Renal and Liver Allografts in the Presence of DSA

  2023cites this paper
• Clinical progress of auxiliary liver transplantation.

  2020cites this paper
• Kidney Graft Outcomes in High Immunological Risk Simultaneous Liver‐Kidney Transplants

  2020cites this paper
• Antibody-mediated rejection: what is the clinical relevance?

  2017cites this paper
• Subclinical Antibody-Mediated Rejection

  2017cites this paper
• Edinburgh Research Explorer 2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection

  2017cites this paper
• Proposed Diagnostic Criteria for Chronic Antibody‐Mediated Rejection in Liver Allografts

  2016cites this paper
• Prevention and treatment of liver allograft antibody-mediated rejection and the role of the ‘two-hit hypothesis’

  2016cites this paper
• Pig Liver Xenotransplantation: A Review of Progress Toward the Clinic

  2016cites this paper
• Pathologic sequelae of allosensitization in liver transplantation.

  2016cites this paper
• Combined heart-liver transplantation: Indications, outcomes and current experience.

  2016cites this paper
• 2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody‐Mediated Rejection

  2016cites this paper
• The clinical relevance of alloantibody in liver transplantation.

  2015cites this paper
• Clinical significance of donor-specific human leukocyte antigen antibodies in liver transplantation.

  2015cites this paper
• Chapter 84 – Histopathology of Liver Transplantation

  2015cites this paper
• The Perioperative Management of Patients Undergoing Combined Heart-Liver Transplantation

  2015cites this paper
• ABO-compatible liver allograft antibody-mediated rejection: an update

  2015cites this paper
• Histopathological Syndromes of Liver Allograft Rejection and Recurrent Disease

  2014cites this paper
• Antibody‐mediated rejection as a contributor to previously unexplained early liver allograft loss

  2014cites this paper
• Acute liver allograft antibody‐mediated rejection: An inter‐institutional study of significant histopathological features

  2014influential citation
• Combined heart and liver transplantation against positive cross-match for patient with hypoplastic left heart syndrome.

  2014cites this paper
• The Role of Donor‐Specific HLA Alloantibodies in Liver Transplantation

  2014cites this paper
• Preformed class II donor‐specific antibodies are associated with an increased risk of early rejection after liver transplantation

  2013cites this paper
• Combined Heart and Liver Transplant Attenuates Cardiac Allograft Vasculopathy Compared with Isolated Heart Transplantation

  2013cites this paper
• Renal allograft outcome in recipients of positive-crossmatch combined liver-kidney transplantation.

  2013cites this paper
• Combined heart and liver transplantation: protection of the cardiac graft from antibody rejection by initial liver implantation.

  2013cites this paper
• Liver transplantation with a strongly positive crossmatch: Case study and literature review

  2013cites this paper
• Significance of True-Positive and False-Positive Pretransplantation Lymphocytotoxic Crossmatch in Primary Liver Allograft Outcomes

  2013cites this paper
• Sinusoidal C4d deposits in liver allografts indicate an antibody‐mediated response: Diagnostic considerations in the evaluation of liver allografts

  2012cites this paper
• Re‐examination of the Lymphocytotoxic Crossmatch in Liver Transplantation: Can C4d Stains Help in Monitoring?

  2012cites this paper
• Combined Liver-Kidney Transplants: Allosensitization and Recipient Outcomes

  2011cites this paper
• Liver allograft antibody‐mediated rejection with demonstration of sinusoidal C4d staining and circulating donor‐specific antibodies

  2011cites this paper
• Does a positive pretransplant crossmatch affect long-term outcome in liver transplantation?

  2011cites this paper
• An in vitro model of pig liver xenotransplantation—pig complement is associated with reduced lysis of wild‐type and genetically modified pig cells

  2010cites this paper
• Seeking Beyond Rejection: An Update on the Differential Diagnosis and a Practical Approach to Liver Allograft Biopsy Interpretation

  2009cites this paper
• Transplantation Pathology of the Liver

  2009cites this paper
• Liver xenografts for the treatment of acute liver failure: Clinical and experimental experience and remaining immunologic barriers

  2008cites this paper
• Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: Role of human leukocyte antigen compatibility

  2008cites this paper
• The liver: a special case in transplantation tolerance.

  2007cites this paper
• Successful Combined Partial Auxiliary Liver and Kidney Transplantation in Highly Sensitized Cross‐Match Positive Recipients

  2007cites this paper
• Usage of deoxyspergualin on steroid-resistant acute rejection in living donor liver transplantation.

  2006cites this paper
• Clinical importance of non-HLA antibodies in solid organ transplantation

  2006cites this paper
• Mechanisms of liver allograft rejections

  2005cites this paper
• Mechanisms of liver allograft rejections

  2005cites this paper
• 69 – Histological Patterns of Rejection and Other Causes of Liver Dysfunction

  2005cites this paper
• 74 – ABO, Tissue Typing, and Cross-match Incompatibility in Liver Transplantation

  2005cites this paper
• Portal capillary C4d deposits and increased infiltration by macrophages indicate humorally mediated mechanisms in acute cellular liver allograft rejection

  2005cites this paper
• Humoral rejection of human organ transplants

  2003cites this paper
• SIGNIFICANCE OF A T-LYMPHOCYTOTOXIC CROSSMATCH IN LIVER AND COMBINED LIVER-KIDNEY TRANSPLANTATION

  2001cites this paper
• Antibody elimination by apheresis in living donor liver transplant recipients.

  2001cites this paper
• The effect of a positive T-lymphocytotoxic crossmatch on hepatic allograft survival and rejection.

  1998cites this paper
• Mechanisms of resistance to injury in pig livers perfused with blood from patients in liver failure.

  1997cites this paper
• Significance of preformed anti-donor antibodies in liver transplantation.

  1997cites this paper
• A positive crossmatch in liver transplantation--no effect or inappropriate analysis? A prospective study.

  1997cites this paper
• Cross-matching in liver transplantation.

  1997cites this paper